314 related articles for article (PubMed ID: 8896300)
21. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
22. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
Mizuno Y; Jacob RF; Mason RP
Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
[TBL] [Abstract][Full Text] [Related]
23. Role of arterial compliance in the physiopharmacological approach to human hypertension.
Simon AC; Levenson J; Chau NP; Pithois-Merli I
J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S11-20. PubMed ID: 1381785
[TBL] [Abstract][Full Text] [Related]
24. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
Mahmud A; Hennessy M; Feely J
J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
[TBL] [Abstract][Full Text] [Related]
25. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z; McEniery CM; Yasmin ; Cockcroft JR; Brown MJ; Wilkinson IB
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community.
Kullo IJ; Seward JB; Bailey KR; Bielak LF; Grossardt BR; Sheedy PF; Peyser PA; Turner ST
Am J Hypertens; 2005 Aug; 18(8):1123-9. PubMed ID: 16109328
[TBL] [Abstract][Full Text] [Related]
27. Towards new indices of arterial stiffness using systolic pulse contour analysis: a theoretical point of view.
Chemla D; Plamann K; Nitenberg A
J Cardiovasc Pharmacol; 2008 Feb; 51(2):111-7. PubMed ID: 18287877
[TBL] [Abstract][Full Text] [Related]
28. On arterial physiology, pathophysiology of vascular compliance, and cardiovascular disease.
Glasser SP
Heart Dis; 2000; 2(5):375-9. PubMed ID: 11728285
[TBL] [Abstract][Full Text] [Related]
29. Central blood pressure as an index of antihypertensive control: determinants and potential value.
Trudeau L
Can J Cardiol; 2014 May; 30(5 Suppl):S23-8. PubMed ID: 24750979
[TBL] [Abstract][Full Text] [Related]
30. Vascular compliance in blood pressure.
Raij L; Gonzalez-Ochoa AM
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):457-64. PubMed ID: 21738031
[TBL] [Abstract][Full Text] [Related]
31. Pulse pressure, arterial stiffness and wave reflections (augmentation index) as cardiovascular risk factors in hypertension.
Safar ME
Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):13-24. PubMed ID: 19124404
[TBL] [Abstract][Full Text] [Related]
32. Large arteries in hypertension. Pharmacological and therapeutic aspects.
Safar ME
Pathol Biol (Paris); 1999 Sep; 47(7):738-43. PubMed ID: 10522264
[TBL] [Abstract][Full Text] [Related]
33. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
[TBL] [Abstract][Full Text] [Related]
34. [Improving the control of systolic hypertension and pulse pressure in elderly population].
Sun N
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1441-2. PubMed ID: 12645505
[No Abstract] [Full Text] [Related]
35. [Systolic, diastolic and pulse pressure: prognostic implications].
Verdecchia P
Ital Heart J Suppl; 2001 Apr; 2(4):369-74. PubMed ID: 19397009
[TBL] [Abstract][Full Text] [Related]
36. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
37. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
Frishman WH
Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
[TBL] [Abstract][Full Text] [Related]
38. Effect of antihypertensive treatment on small artery remodeling in hypertension.
Schiffrin EL
Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
[TBL] [Abstract][Full Text] [Related]
39. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
40. Hypertension and the arterial system: clinical and therapeutic aspects.
Safar ME; Levy BI; Laurent S; London GM
J Hypertens Suppl; 1990 Dec; 8(7):S113-9. PubMed ID: 2095379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
